Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126375453 | 12637545 | 3 | F | 201606 | 20160829 | 20160809 | 20160902 | EXP | US-ACTELION-A-NJ2016-138256 | ACTELION | 72.00 | YR | E | F | Y | 0.00000 | 20160902 | OT | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126375453 | 12637545 | 1 | PS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 6-9XDAY | N | MA02BP4 | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | |||||
126375453 | 12637545 | 2 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | 5 MCG, 6-8 X/DAY | N | MA02DL0 | 21779 | 5 | UG | INHALATION VAPOUR, SOLUTION | |||||
126375453 | 12637545 | 3 | SS | VENTAVIS | ILOPROST | 1 | Respiratory (inhalation) | UNK, 5 X/DAY | N | 21779 | INHALATION VAPOUR, SOLUTION | ||||||||
126375453 | 12637545 | 4 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 200 MCG, BID | N | 031004701 | 207947 | 200 | UG | TABLET | BID | ||||
126375453 | 12637545 | 5 | SS | UPTRAVI | SELEXIPAG | 1 | Oral | 400 MCG, BID | N | 031004701 | 207947 | 400 | UG | TABLET | BID | ||||
126375453 | 12637545 | 6 | C | ADCIRCA | TADALAFIL | 1 | U | 0 | |||||||||||
126375453 | 12637545 | 7 | C | NIFEDIPINE. | NIFEDIPINE | 1 | U | 0 | |||||||||||
126375453 | 12637545 | 8 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126375453 | 12637545 | 1 | Pulmonary arterial hypertension |
126375453 | 12637545 | 4 | Pulmonary arterial hypertension |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126375453 | 12637545 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126375453 | 12637545 | Blood pressure fluctuation | |
126375453 | 12637545 | Cataract operation | |
126375453 | 12637545 | Cellulitis | |
126375453 | 12637545 | Contusion | |
126375453 | 12637545 | Dizziness | |
126375453 | 12637545 | Eye irritation | |
126375453 | 12637545 | Fall | |
126375453 | 12637545 | Headache | |
126375453 | 12637545 | Insomnia | |
126375453 | 12637545 | Joint injury | |
126375453 | 12637545 | Limb injury | |
126375453 | 12637545 | Loss of consciousness | |
126375453 | 12637545 | Oxygen saturation decreased | |
126375453 | 12637545 | Pain | |
126375453 | 12637545 | Peripheral swelling | |
126375453 | 12637545 | Sudden onset of sleep | |
126375453 | 12637545 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126375453 | 12637545 | 1 | 20130718 | 0 | ||
126375453 | 12637545 | 4 | 20160518 | 0 |